Human ZNF312b oncogene is regulated by Sp1 binding to its promoter region through DNA demethylation and histone acetylation in gastric cancer

International Journal of Cancer

Volumn 129, Issue 9, 2011, Pages 2124-2133

  Song, In Sung ^a   Ha, Ga Hee ^a   Kim, Jeong Min ^a   Jeong, So Young ^a   Lee, Han Chul ^a   Kim, Yong Sung ^a   Kim, Yung Jin ^b   Kwon, Taeg Kyu ^c   Kim, Nam Soon ^a  

^a Korea Research Institute of Bioscience and Biotechnology (KRIBB)   (South Korea)

^b Pusan National University   (South Korea)

^c Keimyung University   (South Korea)

Author keywords

DNA methylation; epigenetics; gastric cancer; histone modification; Sp1; ZNF312b

Indexed keywords

5 AZA 2' DEOXYCYTIDINE; BUTYRIC ACID; MITOGEN ACTIVATED PROTEIN KINASE; TRANSCRIPTION FACTOR SP1;

ARTICLE; BISULFATE SEQUENCING; CANCER CELL; CELL PROLIFERATION; CHROMATIN IMMUNOPRECIPITATION; CONTROLLED STUDY; DNA DEMETHYLATION; DNA METHYLATION; DOWN REGULATION; EPIGENETICS; GENE EXPRESSION; HISTONE ACETYLATION; HUMAN; HUMAN CELL; HUMAN TISSUE; ONCOGENE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROMOTER REGION; PYROSEQUENCING; STOMACH CANCER; TRANSCRIPTION INITIATION; ZNF312B ONCOGENE;

ACETYLATION; CELL LINE, TUMOR; CELL PROLIFERATION; DNA METHYLATION; EPIGENESIS, GENETIC; GENE EXPRESSION REGULATION, NEOPLASTIC; GENE ORDER; HISTONES; HUMANS; PROMOTER REGIONS, GENETIC; SP1 TRANSCRIPTION FACTOR; STOMACH NEOPLASMS; TRANSCRIPTION FACTORS; TRANSCRIPTIONAL ACTIVATION;

EID: 79959426070     PISSN: 00207136     EISSN: 10970215     Source Type: Journal    
DOI: 10.1002/ijc.25871     Document Type: Article

References (31)

1. Meireles SI, Cristo EB, Carvalho AF, Hirata R, Jr., Pelosof A, Gomes LI, Martins WK, Begnami MD, Zitron C, Montagnini AL, Soares FA, Neves EJ, et al. Molecular classifiers for gastric cancer and nonmalignant diseases of the gastric mucosa. Cancer Res 2004; 64: 1255-65. (Pubitemid 38235592)
2. Kim JM, Sohn HY, Yoon SY, Oh JH, Yang JO, Kim JH, Song KS, Rho SM, Yoo HS, Kim YS, Kim JG, Kim NS,. Identification of gastric cancer-related genes using a cDNA microarray containing novel expressed sequence tags expressed in gastric cancer cells. Clin Cancer Res 2005; 11: 473-82. (Pubitemid 40116869)
3. Kim NS, Hahn Y, Oh JH, Lee JY, Oh KJ, Kim JM, Park HS, Kim S, Song KS, Rho SM, Yoo HS, Kim YS,. Gene cataloging and expression profiling in human gastric cancer cells by expressed sequence tags. Genomics 2004; 83: 1024-45. (Pubitemid 38726051)
4. Kim B, Bang S, Lee S, Kim S, Jung Y, Lee C, Choi K, Lee SG, Lee K, Lee Y, Kim SS, Yeom YI, et al. Expression profiling and subtype-specific expression of stomach cancer. Cancer Res 2003; 63: 8248-55. (Pubitemid 37549475)
5. Leung SY, Yuen ST, Chu KM, Mathy JA, Li R, Chan AS, Law S, Wong J, Chen X, So S,. Expression profiling identifies chemokine (C-C motif) ligand 18 as an independent prognostic indicator in gastric cancer. Gastroenterology 2004; 127: 457-69. (Pubitemid 39091894)
6. Song IS, Oh NS, Kim HT, Ha GH, Jeong SY, Kim JM, Kim DI, Yoo HS, Kim CH, Kim NS,. Human ZNF312b promotes the progression of gastric cancer by transcriptional activation of the K-ras gene. Cancer Res 2009; 69: 3131-9.
7. Kidokoro T, Tanikawa C, Furukawa Y, Katagiri T, Nakamura Y, Matsuda K,. CDC20, a potential cancer therapeutic target, is negatively regulated by p 53. Oncogene 2008; 27: 1562-71. (Pubitemid 351347882)
8. Scoumanne A, Zhang J, Chen X,. PRMT5 is required for cell-cycle progression and p53 tumor suppressor function. Nucleic Acids Res 2009; 37: 4965-76.
9. Song IS, Wang AG, Yoon SY, Kim JM, Kim JH, Lee DS, Kim NS,. Regulation of glucose metabolism-related genes and VEGF by HIF-1alpha and HIF-1beta, but not HIF-2alpha, in gastric cancer. Exp Mol Med 2009; 41: 51-8.
10. Matsuo-Takasaki M, Lim JH, Beanan MJ, Sato SM, Sargent TD,. Cloning and expression of a novel zinc finger gene, Fez, transcribed in the forebrain of Xenopus and mouse embryos. Mech Dev 2000; 93: 201-4. (Pubitemid 30216513)
11. Hirata T, Nakazawa M, Yoshihara S, Miyachi H, Kitamura K, Yoshihara Y, Hibi M,. Zinc-finger gene Fez in the olfactory sensory neurons regulates development of the olfactory bulb non-cell-autonomously. Development 2006; 133: 1433-43. (Pubitemid 43732957)
12. Mancini DN, Singh SM, Archer TK, Rodenhiser DI,. Site-specific DNA methylation in the neurofibromatosis (NF1) promoter interferes with binding of CREB and SP1 transcription factors. Oncogene 1999; 18: 4108-19. (Pubitemid 29363918)
13. Takizawa T, Nakashima K, Namihira M, Ochiai W, Uemura A, Yanagisawa M, Fujita N, Nakao M, Taga T,. DNA methylation is a critical cell-intrinsic determinant of astrocyte differentiation in the fetal brain. Dev Cell 2001; 1: 749-58. (Pubitemid 33586130)
14. Santoro R, Grummt I,. Molecular mechanisms mediating methylation- dependent silencing of ribosomal gene transcription. Mol Cell 2001; 8: 719-25. (Pubitemid 32946948)
15. Nan X, Ng HH, Johnson CA, Laherty CD, Turner BM, Eisenman RN, Bird A,. Transcriptional repression by the methyl-CpG-binding protein MeCP2 involves a histone deacetylase complex. Nature 1998; 393: 386-9. (Pubitemid 28269714)
16. Hayashi H, Nagae G, Tsutsumi S, Kaneshiro K, Kozaki T, Kaneda A, Sugisaki H, Aburatani H,. High-resolution mapping of DNA methylation in human genome using oligonucleotide tiling array. Hum Genet 2007; 120: 701-11. (Pubitemid 44942854)
17. Herman JG, Baylin SB,. Gene silencing in cancer in association with promoter hypermethylation. N Engl J Med 2003; 349: 2042-54. (Pubitemid 37448928)
18. Momparler RL,. Cancer epigenetics. Oncogene 2003; 22: 6479-83. (Pubitemid 37372327)
19. Itano N, Atsumi F, Sawai T, Yamada Y, Miyaishi O, Senga T, Hamaguchi M, Kimata K,. Abnormal accumulation of hyaluronan matrix diminishes contact inhibition of cell growth and promotes cell migration. Proc Natl Acad Sci USA 2002; 99: 3609-14. (Pubitemid 34252154)
20. Esteller M,. Cancer epigenomics: DNA methylomes and histone-modification maps. Nat Rev Genet 2007; 8: 286-98. (Pubitemid 46439286)
21. Holliday R, Pugh JE,. DNA modification mechanisms and gene activity during development. Science 1975; 187: 226-32.
22. Gonzalgo ML, Hayashida T, Bender CM, Pao MM, Tsai YC, Gonzales FA, Nguyen HD, Nguyen TT, Jones PA,. The role of DNA methylation in expression of the p19/p16 locus in human bladder cancer cell lines. Cancer Res 1998; 58: 1245-52. (Pubitemid 28183215)
23. Goll MG, Bestor TH,. Histone modification and replacement in chromatin activation. Genes Dev 2002; 16: 1739-42. (Pubitemid 34803889)
24. Nguyen CT, Weisenberger DJ, Velicescu M, Gonzales FA, Lin JC, Liang G, Jones PA,. Histone H3-lysine 9 methylation is associated with aberrant gene silencing in cancer cells and is rapidly reversed by 5-aza-2′- deoxycytidine. Cancer Res 2002; 62: 6456-61. (Pubitemid 35364106)
25. Nishida H, Suzuki T, Kondo S, Miura H, Fujimura Y, Hayashizaki Y,. Histone H3 acetylated at lysine 9 in promoter is associated with low nucleosome density in the vicinity of transcription start site in human cell. Chromosome Res 2006; 14: 203-11.
26. Fuks F,. DNA methylation and histone modifications: teaming up to silence genes. Curr Opin Genet Dev 2005; 15: 490-5. (Pubitemid 41262404)
27. Kouzarides T,. Chromatin modifications and their function. Cell 2007; 128: 693-705. (Pubitemid 46273577)
28. Martin C, Zhang Y,. The diverse functions of histone lysine methylation. Nat Rev Mol Cell Biol 2005; 6: 838-49. (Pubitemid 41568733)
29. Shin TH, Paterson AJ, Grant JH, III, Meluch AA, Kudlow JE,. 5-Azacytidine treatment of HA-A melanoma cells induces Sp1 activity and concomitant transforming growth factor alpha expression. Mol Cell Biol 1992; 12: 3998-4006.
30. Zhu WG, Srinivasan K, Dai Z, Duan W, Druhan LJ, Ding H, Yee L, Villalona-Calero MA, Plass C, Otterson GA,. Methylation of adjacent CpG sites affects Sp1/Sp3 binding and activity in the p21(Cip1) promoter. Mol Cell Biol 2003; 23: 4056-65. (Pubitemid 36666412)
31. Zhang Y, Fatima N, Dufau ML,. Coordinated changes in DNA methylation and histone modifications regulate silencing/derepression of luteinizing hormone receptor gene transcription. Mol Cell Biol 2005; 25: 7929-39. (Pubitemid 41262988)